Lilly Asia Ventures and Baidu Ventures helped the drug discovery software provider push its overall funding past the $310m mark.
China-headquartered molecular analytics software provider Insilico Medicine completed a $255m series C round today backed by subsidiaries of pharmaceutical firms Eli Lilly and internet group Baidu. Lilly Asia Ventures and Baidu Ventures joined private equity firm Warburg Pincus, which led the round, and Eight Roads Ventures, a venture capital subsidiary of investment and financial services…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.